These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life. Bhandari N; Rongsen-Chandola T; Bavdekar A; John J; Antony K; Taneja S; Goyal N; Kawade A; Kang G; Rathore SS; Juvekar S; Muliyil J; Arya A; Shaikh H; Abraham V; Vrati S; Proschan M; Kohberger R; Thiry G; Glass R; Greenberg HB; Curlin G; Mohan K; Harshavardhan GV; Prasad S; Rao TS; Boslego J; Bhan MK; Vaccine; 2014 Aug; 32 Suppl 1():A110-6. PubMed ID: 25091663 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of the oral pentavalent rotavirus vaccine in Mali. Sow SO; Tapia M; Haidara FC; Ciarlet M; Diallo F; Kodio M; Doumbia M; Dembélé RD; Traoré O; Onwuchekwa UU; Lewis KD; Victor JC; Steele AD; Neuzil KM; Kotloff KL; Levine MM Vaccine; 2012 Apr; 30 Suppl 1():A71-8. PubMed ID: 22520140 [TBL] [Abstract][Full Text] [Related]
14. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants. Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138 [TBL] [Abstract][Full Text] [Related]
15. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children. Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Armah GE; Sow SO; Breiman RF; Dallas MJ; Tapia MD; Feikin DR; Binka FN; Steele AD; Laserson KF; Ansah NA; Levine MM; Lewis K; Coia ML; Attah-Poku M; Ojwando J; Rivers SB; Victor JC; Nyambane G; Hodgson A; Schödel F; Ciarlet M; Neuzil KM Lancet; 2010 Aug; 376(9741):606-14. PubMed ID: 20692030 [TBL] [Abstract][Full Text] [Related]
17. Safety of a heat-stable rotavirus vaccine among children in Niger: Data from a phase 3, randomized, double-blind, placebo-controlled trial. Coldiron ME; Guindo O; Makarimi R; Soumana I; Matar Seck A; Garba S; Macher E; Isanaka S; Grais RF Vaccine; 2018 Jun; 36(25):3674-3680. PubMed ID: 29752026 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Zaman K; Dang DA; Victor JC; Shin S; Yunus M; Dallas MJ; Podder G; Vu DT; Le TP; Luby SP; Le HT; Coia ML; Lewis K; Rivers SB; Sack DA; Schödel F; Steele AD; Neuzil KM; Ciarlet M Lancet; 2010 Aug; 376(9741):615-23. PubMed ID: 20692031 [TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of pentavalent rotavirus vaccine in a randomized, double-blind, placebo-controlled study in healthy elderly subjects. Lawrence J; He S; Martin J; Schödel F; Ciarlet M; Murray AV Hum Vaccin Immunother; 2014; 10(8):2247-54. PubMed ID: 25424929 [TBL] [Abstract][Full Text] [Related]